Nureca Ltd.

₹257.45

-10.4 (-3.9%)

NURECA Share Price

Healthcare Equipment & Supplies

As on March 13, 2026

SectorHealthcare

IndustryHealthcare Equipment & Supplies

Basic IndustryMedical Equipment & Supplies

Market Cap₹ 247 Cr

P/E Ratio304.31

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	262.34	Bearish
10-DMA	270.84	Bearish
20-DMA	280.08	Bearish
50-DMA	285.99	Bearish
100-DMA	285.1	Bearish
200-DMA	270.67	Bearish

Historical Performance

1 Year

12.3%

3 Years

-24%

5 Years

-57.4%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	1,097	919	1,113	2,555	2,135
Total Expenditure	1,175	1,022	1,263	2,000	1,519
Other Income	127	105	71	77	28
Operating Profit	49	3	-79	632	644
Interest	12	5	4	7	16
Depreciation	23	24	24	15	4
Profit Before Tax	13	-25	-107	610	623
Consolidated Net Profit	8	-18	-82	450	464
Adjusted EPS	1	-2	-8	45	46

Compounded Sales Growth

10 Years:40.5

5 Years:2

3 Years:-15.6

TTM:3.6

Compounded Profit Growth

10 Years:-22.9

5 Years:-33.3

3 Years:-54.8

TTM:-30.4

Stock Price CAGR

10 Years:N/A

5 Years:-14.9

3 Years:-7.6

TTM:12.3

Return on Equity

10 Years:N/A

5 Years:46.4

3 Years:-8.2

last year:0.8

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	100	100	100	100	100
Total Reserves	1,843	1,831	1,849	1,932	1,531
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	-2	-21	1	36	32
Other Current Liabilities	47	30	35	52	54
Short Term Borrowings	8	1	1	1	2
Total Liabilities	2,065	2,003	2,039	2,521	1,903
Capital Work in Progress	---	3	---	---	---
Long Term Loans & Advances	37	3	14	3	1
Currents Investments	10	936	591	332	---
Short Term Loans and Advances	968	171	138	480	159
Total Current Assets	1,900	1,926	1,866	2,392	1,862
Total Assets	2,065	2,003	2,039	2,521	1,903
Adjusted Book Value	194	193	195	203	163

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 304.31, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -7.6%, indicating poor shareholder returns.
The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹49 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1097 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1176645.3

No. of Shares: 4570 (Approx)

Performance:17.7%

P/L: ₹176645.3

NIFTY Performance: 3.4%

1 day Top Gainers